| |
| Speakers |
| |
 |
Chen Xiaoxiang
Vice president, medicine R&D, Boehringer Ingelheim China/Hong Kong/Taiwan |
| |
 |
Shen Huaqiong
Chief medical officer, Jiangsu Hengrui Medicine Co. LTD |
| |
 |
Yu Qin
Legal Specialist, R&D Legal Division, Asia Pacific, Pfizer |
| |
 |
Qiang Shengzhen
Site Contract Leader, PAREXEL International |
| |
 |
Li Huafang
Excutive director, ChinaARO-P
PI, GCP platform, Science and Technology National Major Project for IND
Director, MICT, Shanghai Mental Health Center |
|
|
|
